Back to CGEM
Elmind Capital, LP CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$14.8M
Q3 2026
Peak value
$14.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3.2M |
| Q1 2026 | $7.5M |
| Q2 2026 | $12.6M |
| Q3 2026 | $14.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14.8M | 962.8K | — | — |
| Q2 2026 | $12.6M | 690.0K | — | — |
| Q1 2026 | $7.5M | 530.0K | — | — |
| Q4 2025 | $3.2M | 310.0K | — | — |
Other funds holding CGEM
$177.2M
$163.2M
$163.2M
$149.2M
$137.6M
$127.4M
$108.7M
$104.7M